|Articles|May 31, 2017
Chiltern Acquires Japanese CRO
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development.
Advertisement
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development. Under this acquisition, IDA will do business as a subsidiary of Chiltern and be renamed IDA, a Chiltern Company.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
3
Applying AI to Automate Workflows Without Disrupting Sites
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5